Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep209 | Calcium and Bone | ECE2022

Complications of a rare condition, untreated due to difficult living conditions

Slahor Lea , Christoph Henzen

Introduction: Pseudohypoparathyroidism is a rare disorder characterized by end-organ resistance to parathyroid hormone, caused by molecular defects of the PTH receptor. Resulting chronic hypocalcemia and hyperphosphatemia require lifelong treatment with active vitamin D metabolites and monitoring, representing a challenge especially in difficult living conditions.Case report: A 19-year-old woman presented to our clinic with carpopedal spasms and tetany. ...

ea0063p1052 | Pituitary and Neuroendocrinology 3 | ECE2019

Long-term treatment of chronic refractory SIADH with tolvaptan in the elderly: A report of three cases

Stutz Beryl , Henzen Christoph , Fischli Stefan

Background: Hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a very common electrolyte disorder in older patients leading often to hospital admissions. Symptoms can vary between mild disabilities (e.g. nausea, dizziness, attention deficits, gait disturbance) to severe life-threatening conditions (e.g. seizures, coma). Treatment of SIADH is challenging in particular when fluid restriction is limited or even not effective in restoring n...

ea0037ep1279 | Clinical Cases–Thyroid/Other | ECE2015

Similia similibus curentur: a novel treatment approach in endocrinology?

Streuli Regina , Slahor Lea , Burget Lukas , Henzen Christoph , Fischli Stefan

Introduction: Hyperinsulinaemic hypoglycemia after gastric bypass surgery is a rare but probably underestimated complication. The mechanisms leading to hypoglycemia are complex and incompletely understood and involve several factors: A part from decreasing insulin resistance, caloric restriction and alteration of nutrient delivery, enhanced secretion of insulin and incretins (GLP1 and GIP), altered physiology of other hormones and dysregulation of counterregulatory effectors s...

ea0070ep396 | Reproductive and Developmental Endocrinology | ECE2020

Unusual manifestation of an endocrine-active testicular tumor

Steighardt Anna , Axel Rüfer , Dominik Högger , Christoph Henzen , Stefan Fischli

Introduction: Leydig cell tumors (LCT) are rare testicular tumors, characterized by mostly benign etiology. Due to their secretory activity androgen- and/or estrogen-excess can occur.Case report: A 42-year old patient with recent history of cerebrovascular incident was admitted to the hematology department for diagnostic work-up of new-onset erythrocytosis (hemoglobin 185 g/l [reference 127–163], hematocrit 0.53 [0.37–0.46]). Myeloproliferati...

ea0020p227 | Bone/Calcium | ECE2009

Experience with cinacalcet in primary hyperparathyroidism: results from the Swiss primary hyperparathyroidism cohort study

Meier Christian , Trombetti Andrea , Henzen Christoph , Rohrer Andreas , Hermann F , Braendle Michael , Christ Emanuel , Rizzoli Rene , Kraenzlin Marius

Objective: Cinacalcet, a calcimimetic that reduces parathyroid hormone (PTH) secretion and serum calcium (S-Ca) levels by increasing the sensitivity of calcium-sensing receptors has been introduced for the treatment of patients with persistent or recurrent primary hyperparathyroidism (PHPT). Within a prospective, non-interventional cohort study we identified patients with newly diagnosed PHPT who have been started on cinacalcet. Patient characteristics, treatment indications a...

ea0020p229 | Bone/Calcium | ECE2009

Swiss primary hyperparathyroidism cohort study

Trombetti Andrea , Meier Christian , Kraenzlin Marius E , Herrmann Francois R , Henzen Christoph H , Christ Emmanuel R , Brandle Michael , Rizzoli Rene

Objective: The Swiss Primary HyperParaThyroidism (PHPT) Cohort Study is an ongoing, prospective, non-interventional project collecting clinical, densitometric, biochemical and outcome data in patients with PHPT. The aims are to describe the profile of these patients particularly neurobehavioral and cognitive symptoms, changes in calcium and PTH over time and treatment modalities.Methods: Patients newly diagnosed with PHPT and with high serum calcium leve...

ea0035p18 | Adrenal cortex | ECE2014

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE*' randomized trial

Schuetz Philipp , Leuppi Joerg D , Bingisser Roland , Bodmer Michael , Briel Matthias , Drescher Tillman , Duerring Ursula , Henzen Christoph , Leibbrandt Yolanda , Maier Sabrina , Miedinger David , Muller Beat , Scherr Andreas , Schindler Christian , Stoeckli Rolf , Viatte Sebastien , von Garnier Christophe , Tamm Michael , Rutishauser Jonas

Introduction: Systemic glucocorticoid therapy may put patients at risk for later adrenal failure during times of stress, but tapering increases cumulative steroid exposure. We prospectively evaluated adrenal function and clinically relevant hypocortisolism after abruptly stopping prednisone treatment in patients with exacerbated COPD.Methods: This is a pre-specified analysis of the REDUCE randomized trial (Journal of American Medical Association...